3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
279
Triple Negative Breast Neoplasms
146
Neoplasm Metastasis
27
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
17
Inflammatory Breast Neoplasms
15
Pancreatic Neoplasms
12
Neoplasms
11
Endometrial Neoplasms
11
Breast Neoplasms, Male
11
Colorectal Neoplasms
8
Carcinoma, Ductal, Breast
8
Stomach Neoplasms
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Lung Neoplasms
7
Prostatic Neoplasms
6
Melanoma
6
Fallopian Tube Neoplasms
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Pathologic Complete Response
5
HER2-positive Breast Cancer
5
Carcinoma, Ovarian Epithelial
5
Esophageal Neoplasms
4
Carcinoma, Lobular
4
Urinary Bladder Neoplasms
3
Small Cell Lung Carcinoma
3
Recurrence
3
Multiple Myeloma
3
Interventions
Paclitaxel
3
Doxorubicin
3
Cyclophosphamide
3
Trastuzumab
2
Surgical Procedures, Operative
2
Carboplatin
2
pertuzumab
1
liposomal doxorubicin
1
cemiplimab
1
atezolizumab
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Lapatinib
1
Indocyanine Green
1
Anastrozole
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Invasive Breast Cancer
×
Carboplatin
×
Breast
×
Clear all
NCT04243616
2025-09-05
CemiHALT
Medical College of Wisconsin
Phase 2
Active not recruiting
36 enrolled
NCT03595592
2024-03-06
APTneo
Fondazione Michelangelo
Phase 3
Active not recruiting
650 enrolled